FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3180069894> ?p ?o ?g. }

• W3180069894 endingPage "1796" @default.
• W3180069894 startingPage "1796" @default.
• W3180069894 abstract "Urothelial bladder cancer (BCa) is the ninth most commonly diagnosed cancer worldwide and accounts for approximately 3% of global cancer diagnoses. We are interested in prognostic markers that may characterize tumor cells (TCs) and immune cells (ICs) and their relationship in BCa. A potential candidate marker that meets these criteria is progranulin (GP88), which is expressed separately in TCs and ICs. We analyzed GP88 expression by immunohistochemistry (IHC) in 196 muscle-invasive BCa samples using a tissue microarray. The immunoreactive score for GP88 staining in TCs and the percentage of GP88-positive ICs was determined. An easy cutoff for the staining status of TCs (positive vs. negative) and ICs (0% vs. >0%) and, more generally, negative vs. positive GP88 staining could be applied. We detected 93 patients (47.4%) and 92 patients (46.9%) with GP88-positive TCs or ICs, respectively. The IHC results were correlated with clinicopathological and survival data. Positive GP88 staining in TCs appeared to be an independent poor prognostic factor for disease-specific survival (DSS) (RR (relative risk) = 1.74; p = 0.009) and recurrence-free survival (RFS) (RR = 1.92; p = 0.002). In contrast, negative GP88 staining in ICs was an independent negative predictor for overall survival (OS) (RR = 2.18; p < 0.001), DSS (RR = 2.84; p < 0.001) and RFS (RR = 2.91; p < 0.001) in multivariate Cox's regression analysis. When combining GP88 staining in TCs and ICs, a specific combination of GP88-positive TCs and GP88-negative ICs was associated with a 2.54-fold increased risk of death, a 4.21-fold increased risk of disease-specific death and a 4.81-fold increased risk of recurrence compared to GP88-negative TCs and GP88-positive ICs. In summary, GP88 positivity in TCs is a negative prognostic factor for DSS and RFS. In addition, GP88 positivity can mark ICs that are associated with a good prognosis (OS, DSS and RFS). The combination of GP88 staining in TCs and ICs appears to be a significant independent prognostic biomarker in muscle-invasive BCa." @default.
• W3180069894 created "2021-07-19" @default.
• W3180069894 creator A5000515613 @default.
• W3180069894 creator A5007724212 @default.
• W3180069894 creator A5008267911 @default.
• W3180069894 creator A5016256104 @default.
• W3180069894 creator A5043291150 @default.
• W3180069894 creator A5044131715 @default.
• W3180069894 creator A5049585448 @default.
• W3180069894 creator A5051550342 @default.
• W3180069894 creator A5068189118 @default.
• W3180069894 creator A5073600617 @default.
• W3180069894 creator A5073940197 @default.
• W3180069894 creator A5076204719 @default.
• W3180069894 creator A5079268649 @default.
• W3180069894 creator A5086028372 @default.
• W3180069894 creator A5086220621 @default.
• W3180069894 date "2021-07-15" @default.
• W3180069894 modified "2023-10-16" @default.
• W3180069894 title "Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients" @default.
• W3180069894 cites W1971016258 @default.
• W3180069894 cites W1974744629 @default.
• W3180069894 cites W1982236441 @default.
• W3180069894 cites W1986808693 @default.
• W3180069894 cites W1989398309 @default.
• W3180069894 cites W1990979240 @default.
• W3180069894 cites W1995964922 @default.
• W3180069894 cites W2001060341 @default.
• W3180069894 cites W2012761580 @default.
• W3180069894 cites W2015659076 @default.
• W3180069894 cites W2020719670 @default.
• W3180069894 cites W2026711309 @default.
• W3180069894 cites W2033775272 @default.
• W3180069894 cites W2042356728 @default.
• W3180069894 cites W2046700952 @default.
• W3180069894 cites W2050705743 @default.
• W3180069894 cites W2081272311 @default.
• W3180069894 cites W2086014014 @default.
• W3180069894 cites W2093773243 @default.
• W3180069894 cites W2095973840 @default.
• W3180069894 cites W2098208235 @default.
• W3180069894 cites W2103029879 @default.
• W3180069894 cites W2127898787 @default.
• W3180069894 cites W2155939544 @default.
• W3180069894 cites W2162656610 @default.
• W3180069894 cites W2314605098 @default.
• W3180069894 cites W2396280219 @default.
• W3180069894 cites W2483451962 @default.
• W3180069894 cites W2507406429 @default.
• W3180069894 cites W2509266256 @default.
• W3180069894 cites W2535009445 @default.
• W3180069894 cites W2584071843 @default.
• W3180069894 cites W2689907640 @default.
• W3180069894 cites W2744685612 @default.
• W3180069894 cites W2747578239 @default.
• W3180069894 cites W2786668274 @default.
• W3180069894 cites W2790748465 @default.
• W3180069894 cites W2792856868 @default.
• W3180069894 cites W2899175312 @default.
• W3180069894 cites W2913857335 @default.
• W3180069894 cites W2940349477 @default.
• W3180069894 cites W2995198497 @default.
• W3180069894 cites W3015290467 @default.
• W3180069894 cites W3023288864 @default.
• W3180069894 cites W3024482887 @default.
• W3180069894 cites W3025491372 @default.
• W3180069894 cites W3026060226 @default.
• W3180069894 cites W3047106569 @default.
• W3180069894 cites W3118442307 @default.
• W3180069894 cites W3125304165 @default.
• W3180069894 cites W3128646645 @default.
• W3180069894 cites W3131110927 @default.
• W3180069894 cites W3132292896 @default.
• W3180069894 cites W4211053712 @default.
• W3180069894 doi "https://doi.org/10.3390/cells10071796" @default.
• W3180069894 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8306318" @default.
• W3180069894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34359965" @default.
• W3180069894 hasPublicationYear "2021" @default.
• W3180069894 type Work @default.
• W3180069894 sameAs 3180069894 @default.
• W3180069894 citedByCount "1" @default.
• W3180069894 countsByYear W31800698942023 @default.
• W3180069894 crossrefType "journal-article" @default.
• W3180069894 hasAuthorship W3180069894A5000515613 @default.
• W3180069894 hasAuthorship W3180069894A5007724212 @default.
• W3180069894 hasAuthorship W3180069894A5008267911 @default.
• W3180069894 hasAuthorship W3180069894A5016256104 @default.
• W3180069894 hasAuthorship W3180069894A5043291150 @default.
• W3180069894 hasAuthorship W3180069894A5044131715 @default.
• W3180069894 hasAuthorship W3180069894A5049585448 @default.
• W3180069894 hasAuthorship W3180069894A5051550342 @default.
• W3180069894 hasAuthorship W3180069894A5068189118 @default.
• W3180069894 hasAuthorship W3180069894A5073600617 @default.
• W3180069894 hasAuthorship W3180069894A5073940197 @default.
• W3180069894 hasAuthorship W3180069894A5076204719 @default.
• W3180069894 hasAuthorship W3180069894A5079268649 @default.
• W3180069894 hasAuthorship W3180069894A5086028372 @default.
• W3180069894 hasAuthorship W3180069894A5086220621 @default.

• next